Skip to content
2000
Volume 21, Issue 7
  • ISSN: 1871-5265
  • E-ISSN: 2212-3989

Abstract

Recently, novel coronavirus infection (COVID-19) emerged in Wuhan, China has been declared as pandemic by WHO. Until now, no evidence is documented regarding its wild animal reservoir or intermediary host, but, human-to-human transmission, asymptomatic carriers were very much observed. The number of confirmed cases and death toll have been increased almost all over the world indicating its potential threat to public health. Though the phylogenetic analysis shows some similarity of SARS-CoV2 to bat betacoronaviruses, it exhibited significant variation in S1 domain of spike protein from bat-derived viruses. S1 domain plays an important role in receptor binding and it can be a target for the development of therapeutics and vaccines. In this review, we have discussed the updates on transmission, diagnosis, genome analysis and comparison, treatment options and clinical trials of COVID-19.

Loading

Article metrics loading...

/content/journals/iddt/10.2174/1871526520666201109115820
2021-11-01
2025-04-21
Loading full text...

Full text loading...

/content/journals/iddt/10.2174/1871526520666201109115820
Loading

  • Article Type:
    Research Article
Keyword(s): angiotensin converting enzyme; Antivirals; coronavirus pandemic; COVID-19; SARS-CoV
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test